首页> 外文期刊>Revista Brasileira de Anestesiologia >Uso de dexmedetomidina em anestesia geral para tratamento cirúrgico de aneurisma cerebral, em paciente gestante, portadora de doen?a hipertensiva específica da gesta??o: relato de caso
【24h】

Uso de dexmedetomidina em anestesia geral para tratamento cirúrgico de aneurisma cerebral, em paciente gestante, portadora de doen?a hipertensiva específica da gesta??o: relato de caso

机译:右美托咪定在全身麻醉中用于妊娠特定高血压疾病孕妇的脑动脉瘤手术治疗:病例报告

获取原文
       

摘要

BACKGROUND AND OBJECTIVES: The incidence of non-obstetrical surgeries in pregnant patients is about 0.36% to 2%. However, surgeries aiming at surgical treatment of cerebral aneurysm in pregnant women are extremely rare. Specific hypertensive disease of pregnancy, shows clinical prevalence of 10%. It is a disease with high clinical complexity compromising multiple organs and systems. Dexmedetomidine, a2-adrenoceptor agonist drug, in therapeutic clinical doses has major selectivity for these receptors and promotes suitable hemodynamic stability if used in the preoperative period. The purpose of this report was to present an anesthetic technique able to provide adequate maintenance of maternal homeostasis, preserving to the highest level uterus-placental blood flow and fetal vitality, without neglecting fundamental aspects regarding the optimization of brain oxygen supply/demand ratio and favorable brain tissue conditions for surgical management. CASE REPORT: Pregnant patient, 19 years old, 27 weeks of gestation, was referred to the operating room for surgical treatment of cerebral aneurysm. In the preoperative period she was conscious, oriented, eupneic but with left side motor deficit and clinical signs compatible with toxemia of pregnancy. Dexmedetomidine (1 μg.kg-1.h-1) was administered in 20 minutes, followed by anesthetic induction with propofol (2.5 mg.kg-1), fentanyl (7.5 μg.kg-1), lidocaine (1 mg.kg-1) and rocuronium (1.2 mg.kg-1) in rapid sequence. Anesthesia was maintained with propofol (50 μg.kg-1.min-1), alfentanil (1 μg.kg-1.min-1) and dexmedetomi- dine (0.7 μg.kg-1.h-1). Surgical procedure went on with no complications, including brain sequelae. CONCLUSIONS: This case report has shown that dexmedetomidine made possible the handling of hemodynamic responses, keeping optimized uterus-placental blood flow and fetal vitality. Adequate conditions of surgical brain tissue manipulation and the absence of influence in postoperative morbidity are also emphasized.
机译:背景与目的:孕妇非产科手术的发生率约为0.36%至2%。但是,针对孕妇脑动脉瘤的手术治疗的手术极为罕见。妊娠特定的高血压疾病,显示临床患病率为10%。它是一种具有高度临床复杂性的疾病,会损害多个器官和系统。治疗性临床剂量的右美托咪定,一种α2-肾上腺素能受体激动剂,对这些受体具有主要的选择性,并且如果在术前使用,则可以促进合适的血液动力学稳定性。本报告的目的是介绍一种麻醉技术,该技术能够充分维持孕产妇体内稳态,保持子宫-胎盘的最高血流量和胎儿活力,而又不忽略有关优化脑氧供需比的基本方面。脑组织状况适合手术管理。病例报告:孕妇,19岁,妊娠27周,被转介到手术室进行脑动脉瘤的手术治疗。在术前,她神志清醒,定向,委婉,但左侧运动功能减退,临床体征与妊娠毒血症相符。在20分钟内施用右美托咪定(1μg.kg-1.h-1),然后用异丙酚(2.5 mg.kg-1),芬太尼(7.5μg.kg-1),利多卡因(1 mg.kg)进行麻醉诱导-1)和罗库溴铵(1.2 mg.kg-1)的快速序列。丙泊酚(50μg.kg-1.min-1),阿芬太尼(1μg.kg-1.min-1)和右美托咪定(0.7μg.kg-1.h-1)维持麻醉。手术过程没有发生任何并发症,包括脑后遗症。结论:该病例报告表明右美托咪定使得处理血液动力学反应成为可能,并保持最佳的子宫胎盘血流量和胎儿活力。还强调了手术脑组织操作的适当条件以及术后发病率的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号